Revenio Group Oyj (OTCMKTS:REVXF – Get Free Report) was the recipient of a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 216 shares, a decline of 97.0% from the April 15th total of 7,129 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ? days.
Revenio Group Oyj Stock Performance
Revenio Group Oyj stock remained flat at $19.17 during mid-day trading on Monday. The stock has a fifty day simple moving average of $19.17 and a two-hundred day simple moving average of $23.00. Revenio Group Oyj has a 1-year low of $19.17 and a 1-year high of $31.47.
About Revenio Group Oyj
Revenio Group Oyj is a Finland?based medical technology company specializing in ophthalmic diagnostic instruments. The company’s core business centers on the design, manufacture and sales of intraocular pressure (IOP) measurement devices that support glaucoma screening, diagnosis and long?term patient monitoring. Utilizing patented rebound tonometry technology, Revenio’s tonometers provide rapid, non-invasive IOP readings without the need for topical anesthesia, making them well?suited for both clinical and home settings.
Revenio’s product portfolio is anchored by the Icare® family of tonometers, which includes the Icare PRO for clinical use and the Icare HOME for patient self-monitoring.
See Also
- Five stocks we like better than Revenio Group Oyj
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Revenio Group Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revenio Group Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
